![]() |
||
|
Polyketides Polyketides are natural products which provide a staggering range of clinically effective drugs. These include antibiotics (erythromycin A, monensin A, rifamycin S), immunosuppressants (rapamycin, FK506), antifungal (amphotericin B), antiparasitic (avermectin) and anticancer (doxorubicin) drugs. Not surprisingly polyketides generate great commercial interest and account for medicinal sales in excess of $10 billion per annum. |
||
Polyketide Biosynthesis - Type I Polyketide Sythases Type I modular polyketide synthases (PKS) were identified in 1990. These giant catalytic enzymes are molecular assembly lines which contain multiple active sites on a single polypetide. In the case of erythromycin biosynthesis the polyketide macrocycle is produced by three enzymes DEBS1, DEBS2, and DEBS3, which function as a complex of molecular weight ~ 2 MDa. Each protein contains numerous domains, each possessing catalytic activity to extend and alter the structure of the polyketide as it passes along the protein. The domains are grouped into extension modules. Each module specifies the chemical structure added to the growing polyketide at each stage.
The propionyl group is then transferred to a ketosynthase domain (KS). Subsequently, the polyketide chain is extended by condensation with methylmalonate (from methylmalonyl CoA) pre-loaded on the ACP domain of an extension module.
This process continues along the PKS and other domains such as the ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains can reduce each carbonyl group accordingly. Because the erythromycin PKS has one loading module and six extension modules, the result is a heptaketide chain. The polyketide is then released from the enzyme by a thioesterase domain and post PKS enzymes such as glycosyl- and methyltransferases complete the biosynthesis.
Non-natural PKS - Combinatorial Biosynthesis The modular nature of these proteins provides an opportunity to replace or substitute individual domains or entire modules to produce a non-natural PKS that will introduce different polyketide units or alter the stereochemistry or functionality in the macrocycle. For instance, the loading domain (AT-ACP) of DEBS1 was replaced by the loading module from the avermectin PKS. This alternative loading module accepts a wider range of starting units such as isobutryrate and 2-methylbutyrate in addition to the acetate and propionyl units accepted by the DEBS1 loading module.
Erythromycin A (left), Erythromycin with isobutyryl starter (right) In another example, module 2 from the rapamycin PKS gene cluster was inserted into the eryAI gene that encodes DEBS1. The resulting non-natural synthase produced several new compounds including polyketides with a larger macrolactone, derived from an octaketide.
|
||
|
Post PKS enzymes Post PKS enzymes are also of significant interest because often the structural alterations they introduce are essential for biological activity. It is of great interest to discover the exact sequence of events and the identity of the intermediates in the overall process. For example, specific deletion of a single post PKS gene in the monensin gene cluster led to accumulation of a triene whose structure differs revealingly from the final monensin A product, as shown below.
|
||
|
Type I Polyketide Synthase Gene Clusters An increasing number of the gene clusters responsible for the biosynthesis of polyketide antibiotics have been discovered. The gene cluster responsible for the biosynthesis of erythromycin was the first example of a type I PKS to be discovered. This cluster consists of 3 massive PKS genes (approximately 30 kbp in total size which encode for DEBS1, DEBS2 and DEBS3) and 19 non-PKS genes. The organisation of the genes in the erythromycin producing cluster is shown below.
In addition to the sequencing of PKS clusters, the entire genome of certain Streptomyces bacteria have been sequenced. In conjunction with the Department of Biochemistry DNA Sequencing Facility, we recently published the entire sequence of Saccharopolyspora erythraea, an erythromycin-producing bacterium.
|
||